The Safe Start Trial - Kisumu, Kenya
Primary Purpose
Enteric Infections, Diarrhea
Status
Completed
Phase
Not Applicable
Locations
Kenya
Study Type
Interventional
Intervention
Safe Start
Active Control
Sponsored by
About this trial
This is an interventional prevention trial for Enteric Infections
Eligibility Criteria
Inclusion Criteria:
- Infant is 21-23 weeks of age at enrolment
- Infant's mother residing within catchment of participating health extension worker at time of enrolment and intends to stay in current dwelling at least until infant reaches 37 weeks of age
Exclusion Criteria:
- Infant with any medical, psychiatric or social condition which, in the opinion of the research team, impedes the participant's ability to give informed consent
Sites / Locations
- Great Lakes University Kisumu
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Intervention
Control
Arm Description
Participant households will receive 4 visits by health extension workers delivering intervention
Participant households will receive 4 visits by health extension workers delivering standard care
Outcomes
Primary Outcome Measures
Enteric infection prevalence
Enteric infections are defined as the presence of enteric pathogens in stool as indicated by 1 or more of these 23 genetic sequences: Shigella/EIEC virulence plasmid, EAEC_aaic, EAEC_aata, EPEC_eae, EPEC_bfpa, ETEC_LT, ETEC_STp_STh, EHEC Escherichia coli 0157, Aeromonas, Vibrio cholerae, Campylobacter jejuni/C. coli, Clostridium difficile, and Salmonella enterica), Adenovirus 40/41, Adenovirus Hexon, Norovirus GI, Norovirus GII, and Rotavirus and broad reactive Cryptosporidium_18s, C. hominus, C. parvum, and Giardia assemblages A & B.
Diarrhoeal disease longitudinal prevalence
Longitudinal prevalence is defined by days with diarrhoea during follow-up with diarrhoea defined according to WHO definition (3 or more loose or liquid stools passed within 24 hours)
Secondary Outcome Measures
Full Information
NCT ID
NCT03468114
First Posted
March 5, 2018
Last Updated
August 20, 2019
Sponsor
London School of Hygiene and Tropical Medicine
Collaborators
Great Lakes University Kisumu, University of Iowa
1. Study Identification
Unique Protocol Identification Number
NCT03468114
Brief Title
The Safe Start Trial - Kisumu, Kenya
Official Title
The Safe Start Trial: a Cluster Randomised Controlled Trial for the Effect of a Food Hygiene Intervention on Infant Enteric Infections and Diarrhoeal Disease in Low-income Informal Settlements of Kisumu, Kenya.
Study Type
Interventional
2. Study Status
Record Verification Date
August 2019
Overall Recruitment Status
Completed
Study Start Date
March 26, 2018 (Actual)
Primary Completion Date
May 9, 2019 (Actual)
Study Completion Date
June 22, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
London School of Hygiene and Tropical Medicine
Collaborators
Great Lakes University Kisumu, University of Iowa
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This a cluster randomised controlled trial (cRCT) to evaluate the effect of a novel food hygiene intervention on infant health.
Detailed Description
Enteric infections remain a major threat to child health and development in many low and middle-income countries. Globally, diarrhoeal disease - a key health consequence of enteric infection - is ranked as the fourth leading cause of disability globally, after ischaemic heart disease, lower respiratory tract infections and strokes. Diarrhoeal disease persists as the second leading cause of child deaths in the world, and in sub-Saharan Africa is the leading cause of child deaths.
Public health efforts to address diarrhoeal disease have largely focused on improving access to safe drinking water and sanitation and promoting hand washing with soap to address faecal-oral routes of transmission. These interventions though may not effectively address all exposure pathways during early life, when young children are most susceptible to infection and the diarrhoeal disease burden is greatest. One potentially important exposure pathway is infant food which recent studies conducted in low income, high burden settings suggest may be highly contaminated and may be amenable to simple behaviour change interventions.
The Safe Start trial will evaluate the effect of a novel food hygiene intervention on infant health implemented in low income urban neighbourhoods of Kisumu, Kenya. The intervention is designed to target early childhood exposure to enteric pathogens through contaminated food and was developed through an earlier phase of formative behavioural and microbiological research. The intervention will target infant caregivers and be delivered through the Community Health Volunteer (CHV) health extension system. Four key behaviours will be addressed by the intervention:
Safe hand hygiene: handwashing with soap before infant food preparation and feeding
Safe food preparation: bringing all infant food to the boil before feeding, including when reheating
Safe storage of food: storing all infant food in sealed containers
Safe feeding: reserving specific feeding utensils for the infant and keeping these separate and clean
A cluster randomized controlled trial (cRCT) design will be used to evaluate the intervention with each CHV catchment area forming one cluster. The outcomes of interest for this study are as follows: (1) the prevalence of enteric infections among infants at 37 weeks of age (primary); (2) the longitudinal prevalence of diarrhoea between 22-37 weeks of age (primary); and (3) incidence of all-cause mortality between 22-37 weeks of age. Infants will be recruited on a rolling basis at 22 weeks of age (+/- 1 week), and data and/or samples collected at 3 points: baseline at 22 weeks of age (+/- 1 week); midline at 33 weeks of age (+/- 1 week); and endline at 37 weeks of age (+/- 1 week). Stool samples will be collected at baseline and endline and analysed for 23 genetic sequences indicating the presence of enteric pathogens known to cause childhood diarrhoea in low income, high burden settings.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Enteric Infections, Diarrhea
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Masking Description
Outcome assessors are not informed of allocation but would likely infer this from the presence of highly visible domestic products that are part of the intervention. Lab technicians and data analysts are masked to allocation status.
Allocation
Randomized
Enrollment
880 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Intervention
Arm Type
Experimental
Arm Description
Participant households will receive 4 visits by health extension workers delivering intervention
Arm Title
Control
Arm Type
Active Comparator
Arm Description
Participant households will receive 4 visits by health extension workers delivering standard care
Intervention Type
Behavioral
Intervention Name(s)
Safe Start
Intervention Description
Participant households will receive four visits over a 10 week period from health extension workers promoting safe food preparation, storage and feeding, and will be provided with products to support these practices (a bowl, spoon, cup, hand washing station, liquid soap dispenser).
Intervention Type
Behavioral
Intervention Name(s)
Active Control
Intervention Description
Participant households will receive 4 visits by health extension workers delivering standard care
Primary Outcome Measure Information:
Title
Enteric infection prevalence
Description
Enteric infections are defined as the presence of enteric pathogens in stool as indicated by 1 or more of these 23 genetic sequences: Shigella/EIEC virulence plasmid, EAEC_aaic, EAEC_aata, EPEC_eae, EPEC_bfpa, ETEC_LT, ETEC_STp_STh, EHEC Escherichia coli 0157, Aeromonas, Vibrio cholerae, Campylobacter jejuni/C. coli, Clostridium difficile, and Salmonella enterica), Adenovirus 40/41, Adenovirus Hexon, Norovirus GI, Norovirus GII, and Rotavirus and broad reactive Cryptosporidium_18s, C. hominus, C. parvum, and Giardia assemblages A & B.
Time Frame
At 37 weeks of age (+/- 1 week)
Title
Diarrhoeal disease longitudinal prevalence
Description
Longitudinal prevalence is defined by days with diarrhoea during follow-up with diarrhoea defined according to WHO definition (3 or more loose or liquid stools passed within 24 hours)
Time Frame
Between 22 and 37 weeks of age (+/- 1 week)
Other Pre-specified Outcome Measures:
Title
All-cause mortality incidence
Description
Deaths occurring during follow-up due to any cause
Time Frame
Between 22 and 37 weeks of age (+/- 1 week)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
21 Weeks
Maximum Age & Unit of Time
23 Weeks
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Infant is 21-23 weeks of age at enrolment
Infant's mother residing within catchment of participating health extension worker at time of enrolment and intends to stay in current dwelling at least until infant reaches 37 weeks of age
Exclusion Criteria:
Infant with any medical, psychiatric or social condition which, in the opinion of the research team, impedes the participant's ability to give informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Oliver Cumming, MSc
Organizational Affiliation
London School of Hygiene and Tropical Medicine
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jane Mumma, PhD
Organizational Affiliation
Great Lakes University Kisumu
Official's Role
Principal Investigator
Facility Information:
Facility Name
Great Lakes University Kisumu
City
Kisumu
Country
Kenya
12. IPD Sharing Statement
Citations:
PubMed Identifier
36316067
Citation
Baker KK, Mumma JAO, Simiyu S, Sewell D, Tsai K, Anderson JD, MacDougall A, Dreibelbis R, Cumming O. Environmental and behavioural exposure pathways associated with diarrhoea and enteric pathogen detection in 5-month-old, periurban Kenyan infants: a cross-sectional study. BMJ Open. 2022 Oct 31;12(10):e059878. doi: 10.1136/bmjopen-2021-059878.
Results Reference
derived
PubMed Identifier
31856747
Citation
Mumma J, Simiyu S, Aseyo E, Anderson J, Czerniewska A, Allen E, Dreibelbis R, Baker KK, Cumming O. The Safe Start trial to assess the effect of an infant hygiene intervention on enteric infections and diarrhoea in low-income informal neighbourhoods of Kisumu, Kenya: a study protocol for a cluster randomized controlled trial. BMC Infect Dis. 2019 Dec 19;19(1):1066. doi: 10.1186/s12879-019-4657-0.
Results Reference
derived
Learn more about this trial
The Safe Start Trial - Kisumu, Kenya
We'll reach out to this number within 24 hrs